

Auvelity: 4 Controversies
15 snips Feb 12, 2024
Dr. Chris Aiken and Kellie Newsome discuss controversies around Auvelity, a fast-acting antidepressant, examining side effects, addictive potential, and generic components. They explore the combination of dextromethorphan and bupropion, generic substitution risks, treatment options for resistant depression, and concerns about long-term efficacy and medication use.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Exploring the Combination of Dextromethorphin and Bupropion in Treating Depression and Controversies Surrounding Dextromethorphin
02:06 • 3min
Controversy around Generic Substitution and Alternative Options for Oveleti
05:08 • 2min
Treating Treatment-Resistant Depression with Vellity
07:11 • 4min
Exploring Treatment Duration and Efficacy
11:04 • 6min